Off-label medication use.
Robert H Howland
文献索引：J. Psychosoc. Nurs. Ment. Health Serv. 50(9) , 11-3, (2012)
全文：HTML全文
摘要
Prescribing medications for off-label uses is not illegal. Off-label prescribing includes using medications for unapproved indications; using a drug outside of the recommended dosage range or duration of use; using a drug in certain unapproved patient populations, such as those defined by age, sex, or particular clinical parameters; or intentionally using a medication in a patient who has a known contraindication. Medications would be considered appropriate for off-label use based on their known clinical pharmacology, evidence from clinical studies, and sometimes from the personal experience of the prescriber. The decision to use a drug off label should be based on a careful assessment of the patient's treatment history and the drug's potential risks and benefits. Patients should be given adequate informed consent about how the drug is being used off label and why, along with appropriate information about known risks and side effects.Copyright 2012, SLACK Incorporated.
相关化合物
| 结构式 | 名称/CAS号 | 分子式 | 全部文献 |
|---|---|---|---|
 |
芬特明
CAS:122-09-8 |
C10H15N |
|
Recent advancements in drug treatment of obesity.
2012-10-01 [Clin. Med. 12(5) , 456-60, (2012)] |
|
Therapies for obesity and medication-associated weight gain.
2013-05-01 [J. Psychosoc. Nurs. Ment. Health Serv. 51(5) , 13-6, (2013)] |
|
Phentermine/topiramate for the treatment of obesity.
2013-03-01 [Ann. Pharmacother. 47(3) , 340-9, (2013)] |
|
Obesity drug therapy.
2013-09-01 [Minerva Endocrinol. 38(3) , 245-54, (2013)] |
|
The new weight-loss drugs, lorcaserin and phentermine-topira...
2014-04-01 [JAMA Intern. Med. 174(4) , 615-9, (2014)] |